Effects of CBT-Based Intervention Among Patients With Liver Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Nethersole School of Nursing
About this trial
This study investigates the effects of a CBT- based intervention on depression, anxiety, immune function, quality of life, and overall survival. It also explores if the effects of the intervention on immune function and quality of life are mediated through the improvements in depression and anxiety among patients with liver cancer.
Eligibility criteria
Qualifiers
Adults (aged ≥18);
Diagnosed with liver cancer based on pathological findings or imaging findings in the medical record;
The severity level of depression and anxiety: Depression > 7 using HAD-D, or Anxiety > 7 using HAD-A (Hospital Anxiety and Depression Scale, HADS; HAD-D, Hospital Depression Scale; HAD-A, Hospital Anxiety Scale).
Disqualifiers
Patients who are taking part in another psychological intervention clinical trial or consented to receive another psychotherapy, suffered from aphasia and other communication difficulties will be excluded from the study
Patients with active immunological diseases, such as autoimmune diseases, and inflammatory diseases.
Patients accepting hormone therapy or taking long-term antibiotic drugs.
Patients who lack the basic ability of understanding and expression and are incompetent in giving consent.
Trial design
Treatments tested in this trial
- Cognitive behavioural therapy-based intervention
- Educational group
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
The Nethersole School of Nursing
Lead sponsor
ZhuHai Hospital
Collaborator
Source ClinicalTrials.gov